Press Releases
23Oct, 2013
Alzheon Launches with Veteran Team and Funding to Accelerate Drug Development in Alzheimer’s Disease and Other Neurodegenerative Disorders
Company Obtains Exclusive License to Novel Clinical Alzheimer’s Disease Drug Candidate and Platform Developed by BELLUS Health Company to Advance ALZ-801 into Phase 2 Clinical Study [...]